Abstract
To investigate the effects of age and disease on endogenous cardiac progenitor cells, we obtained right atrial and left ventricular epicardial biopsies from patients (n = 22) with chronic ischaemic heart disease and measured doubling time and surface marker expression in explant- and cardiosphere-derived cells (EDCs, CDCs). EDCs could be expanded from all atrial biopsy samples, but sufficient cells for cardiosphere culture were obtained from only 8 of 22 ventricular biopsies. EDCs from both atrium and ventricle contained a higher proportion of c-kit+ cells than CDCs, which contained few such cells. There was wide variation in expression of CD90 (atrial CDCs 5-92 % CD90+; ventricular CDCs 11-89 % CD90+), with atrial CDCs cultured from diabetic patients (n = 4) containing 1.6-fold more CD90+ cells than those from non-diabetic patients (n = 18). No effect of age or other co-morbidities was detected. Thus, CDCs from atrial biopsies may vary in their therapeutic potential. © 2012 The Author(s).
Author supplied keywords
Cite
CITATION STYLE
Chan, H. H. L., Meher Homji, Z., Gomes, R. S. M., Sweeney, D., Thomas, G. N., Tan, J. J., … Carr, C. A. (2012). Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsies. Journal of Cardiovascular Translational Research, 5(5), 678–687. https://doi.org/10.1007/s12265-012-9389-0
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.